(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

EPISEQ

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

EPISEQ

ST13

US500000079180552

Classe

1, 5, 9, 35, 38, 41, 42

Pedido

79180552

Registro

5080079

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

57

Atualização mais recente

03/04/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5, 9, 35, 38, 41, 42

Data de depósito

13/08/2015

Data de registro

15/11/2016

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

24/06/2023

Última transação

03/04/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

708

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

F-69280 MARCY L'ETOILE, FR

Examinador

MALASHEVICH, JASON

Unidade examinadora

M50

Titulares e representantes

Titulares

bioMérieux
bioMérieux

Representantes

Martin M. Zoltick Rothwell, Figg, Ernst & Manbeck, PC

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 9Classe 35Classe 38Classe 41Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Chemicals and chemical reagents for non-medical purposesfor use in science and scientific research in laboratories; chemicals and chemical reagents for non-medical purposesfor use in science and scientific research in the fields of gene sequencingdiseasesepidemiologydisease infections

Classe 5

Reagents for medicalclinicalveterinary and healthcare uses; chemical reagents for pharmaceutical usefor healthcare-associated infectionsdiseases and epidemics; reagents for clinical or medical use in the fields of gene sequencingdiseasesepidemiology and disease infections

Classe 9

Software for data collection and analysis for use in the fields of sciencemedicineveterinarymedical research and health; downloadable databases in the fields of sciencemedicineveterinarymedical researchhealth; software for data collection and analysisfor use in the fields of gene sequencingdiseasesepidemiology and disease infections; downloadable databases in the fields of gene sequencingdiseasesepidemiologydisease infections; software for detecting micro-organisms and performing epidemiological analysis; downloadable databases in the field of detecting micro-organisms and epidemiological analysis; software for epidemiological surveillance and comparisons; downloadable databases in the field of epidemiological surveillance and comparisons

Classe 35

Processing and collecting gene sequencing datadisease dataepidemiology datadisease infection data for business purposes; updating and correction of data in computer databases relating to the fields of gene sequencingdiseasesepidemiology and disease infections; advertisingmarketingpromotional servicescreating marketingadvertisingpromotional material and documentsfor customers in the scientificmedicalveterinaryresearch and health fields; providing commercial information in the field of science and medicine for customers in the scientificmedicalveterinaryresearch and health fields

Classe 38

Electronic transmission of datainformation and report documents via wireless communications networks; providing access to databases and global computer networks; providing internet chat rooms for transmitting messagesimages and files; all the aforementioned services in the field of gene sequencingdiseasesepidemiologydisease infections

Classe 41

Educational servicesproviding training classes in the fields of sciencemedicineveterinaryscientific research techniques and health; written text editingediting methodical reports on data in the fields of gene sequencingdiseasesepidemiologydisease infections

Classe 42

Engineering study in the field of medicineveterinaryhealthgene sequencingdiseasesepidemiologydisease infectionsepidemiological monitoring and comparisons; scientific research and analysis in the field of gene sequencingdiseasesepidemiologydisease infectionsepidemiological monitoring and comparisons; industrial research in the fields of gene sequencingdiseasesepidemiologydisease infectionsepidemiological monitoring and comparisons; biotechnological research in the fields of gene sequencingdiseasesepidemiologydisease infectionsepidemiological monitoring and comparisons; bacteriological research in the fields of gene sequencingdiseasesepidemiologydisease infectionsepidemiological monitoring and comparisons; biological research in the fields of gene sequencingdiseasesepidemiologydisease infectionsepidemiological monitoring and comparisons; laboratory workscientific researchtestinganalysis and providing scientific information in the fields of gene sequencingdiseasesepidemiologydisease infectionsepidemiological monitoring and comparisons; engineering study in the fields of gene sequencingdiseasesepidemiologydisease infectionsepidemiological monitoring and comparisons for laboratories or industry; developing protocols for simulating and validating experiments or a series of experiments in traffic testing laboratories; consulting services in the field of laboratory workplace automation; designdevelopmentmaintenanceinstallationrepair and updating of computer software used for processing and interpreting results in the fields of scienceresearchmedicineveterinaryhealth; designdevelopmentmaintenanceinstallationrepair and updating of computer software used for processing and interpreting research results in the fields of gene sequencingdiseasesepidemiology and disease infections; electronic storage of data in the fields of gene sequencingdiseasesepidemiology and disease infections; hosting of digital content on remote internet serversthe electronic data and databases of others; hosting internet sites on remote servers for others; hosting the computer software platforms of others on remote servers

Publicações

Histórico de despachos e eventos da marca no USPTO.

57 publicações encontradas

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/04/2026

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

01/04/2026

EWOR

TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

01/04/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/04/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/04/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

01/04/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

01/04/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

05/02/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

22/11/2025

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

15/11/2025

RNWL

INTERNATIONAL REGISTRATION RENEWED

08/05/2025

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

07/04/2024

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

01/04/2024

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

04/03/2024

INPC

INVALIDATION PROCESSED

04/03/2024

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

24/02/2024

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

24/06/2023

C75P

REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.

24/06/2023

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

14/06/2023

PR75

POST REGISTRATION ACTION MAILED - SEC. 71 & 15

02/06/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

28/05/2023

ES75

TEAS SECTION 71 & 15 RECEIVED

14/11/2022

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

15/11/2021

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

04/08/2017

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

06/03/2017

XXCR

GENERIC MADRID TRANSACTION CREATED

06/03/2017

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

15/02/2017

R.PR

REGISTERED-PRINCIPAL REGISTER

15/11/2016

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

09/09/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

30/08/2016

PUBO

PUBLISHED FOR OPPOSITION

30/08/2016

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

10/08/2016

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

10/08/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/08/2016

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

25/07/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

19/07/2016

XAEC

EXAMINER'S AMENDMENT ENTERED

19/07/2016

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

19/07/2016

GNEA

EXAMINERS AMENDMENT E-MAILED

19/07/2016

CNEA

EXAMINERS AMENDMENT -WRITTEN

19/07/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

25/06/2016

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

25/06/2016

ALIE

ASSIGNED TO LIE

25/06/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

20/06/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

20/06/2016

NREP

NEW REPRESENTATIVE AT IB RECEIVED

16/06/2016

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/04/2016

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/04/2016

RFNT

REFUSAL PROCESSED BY IB

13/02/2016

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

22/01/2016

RFRR

REFUSAL PROCESSED BY MPU

22/01/2016

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

21/01/2016

CNRT

NON-FINAL ACTION WRITTEN

20/01/2016

MAFR

APPLICATION FILING RECEIPT MAILED

19/01/2016

DOCK

ASSIGNED TO EXAMINER

15/01/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

15/01/2016

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

14/01/2016

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace EPISEQ ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.